drugset / Trial / NCT00506168
Study of Irinotecan & Capecitabine in Metastatic Colorectal Cancer
NaSingle-groupOpen-labelTreatment
Summary
This study is to evaluate the efficacy and safety of combination chemotherapy with irinotecan and capecitabine in previously untreated metastatic colorectal cancer.
Timeline
- Start
- 2001-11
- Primary completion
- —
- Completion
- 2007-07
Outcome
Outcome not reported
Stopped: “The study drugs are not covered anymore by insurance.”
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Capecitabine | Small molecule | 750 unknown | — |
| Subject | Capecitabine | Small molecule | 1000 mg/m2 | — |
| Subject | Irinotecan | Small molecule | 60 mg/m2 | — |
| Subject | Irinotecan | Small molecule | 100 mg/m2 | — |